| Title: | Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank |
| Journal: | Nature Cardiovascular Research |
| Published: | 25 Sep 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39322770/ |
| DOI: | https://doi.org/10.1038/s44161-024-00545-6 |
Publication 13440
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Several large-scale studies have measured plasma levels of the proteome in individuals with cardiovascular diseases (CVDs)1-7. However, since the majority of such proteins are interrelated2, it is difficult for observational studies to distinguish which proteins are likely to be of etiological relevance. Here we evaluate whether plasma levels of 2,919 proteins measured in 52,164 UK Biobank participants are associated with incident myocardial infarction, ischemic stroke or heart failure. Of those proteins, 126 were associated with all three CVD outcomes and 118 were associated with at least one CVD in the China Kadoorie Biobank. Mendelian randomization and colocalization analyses indicated that genetically determined levels of 47 and 18 proteins, respectively, were associated with CVDs, including FGF5, PROCR and FURIN. While the majority of protein-CVD observational associations were noncausal, these three proteins showed evidence to support potential causality and are therefore promising targets for drug treatment for CVD outcomes.</p>
20 Keywords
- Aged
- Biological Specimen Banks
- Biomarkers
- Blood Proteins
- Cardiovascular Diseases
- China
- Female
- Genetic Predisposition to Disease
- Heart Failure
- Humans
- Incidence
- Ischemic Stroke
- Male
- Mendelian Randomization Analysis
- Middle Aged
- Myocardial Infarction
- Phenotype
- Risk Assessment
- UK Biobank
- United Kingdom
5 Authors
- Lars Lind
- Mohsen Mazidi
- Robert Clarke
- Derrick A. Bennett
- Rui Zheng
1 Application
| Application ID | Title |
|---|---|
| 90143 | USING GENETICS, PROTEOMICS AND METABOLOMICS IN THE STUDY OF CARDIOMETABOLIC DISEASE |
Enabling scientific discoveries that improve human health